课题基金 / 基金详情

To elucidate the pathogenesis of Parkinson' s disease and to develop a new therapy for the disease

To elucidate the pathogenesis of Parkinson' s disease and to develop a new therapy for the disease
阐明帕金森病的发病机制并开发治疗该病的新疗法
批准号:
20023028
负责人:
HATTORI Nobutaka
金额:
$24.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2009

项目摘要

项目成果

HATTORI Nobutaka的其他基金

相似基金

相关文献

中文摘要
翻译
Parkin和PINK1揭示了泛素化和线粒体完整性是疾病发病的关键因素。在这项研究中,我们发现PINK1在稳态条件下以线粒体膜电位依赖的方式快速和组成性地降解,并且线粒体膜电位的损失稳定了PINK1的线粒体积累。此外,PINK1将Parkin从细胞质中招募到低膜电位的线粒体,启动受损线粒体的自噬降解。此外,我们还利用来自parkin KO小鼠的β细胞分析了胰岛素分泌系统。我们发现胰岛素分泌系统的第一阶段选择性损伤。这一发现可用于阐明神经元细胞死亡的发病机制。此外,我们分析了野生型和突变型ATP13A2的细胞定位变化,ATP13A2是Park9的致病基因。野生型定位于溶酶体的外膜。相反,突变体位于内质网。定位的差异会引起功能缺失效应。
英文摘要
Parkin and PINK1 has revealed that ubiquitylation and mitochondrial integrity are key factors in disease pathogenesis. In this study, we show that PINK1 is rapidly and constitutively degraded under steady-state conditions in a mitochondrial membrane potential-dependent manner and that a loss in mitochondrial membrane potential stabilizes PINK1 mitochondrial accumulation. Furthermore, PINK1 recruits Parkin from the cytoplasm to mitochondria with low membrane potential to initiate the autophagic degradation of damaged mitochondria. In addition, we analyzed the secretion system of insulin using beta-cells originated from parkin KO mice. We identified selective impairments of phase I of insulin secretion system. This finding could be available for elucidating the pathogenesis of neuronal cell death. Moreover, we analyzed the alteration of cellular localization of both wild and mutant types of ATP13A2 that is a causative gene for Park9. The wild type localized on the outer membrane of lysosome. In contrast, the mutants located in the endoplasmic reticulum. The difference of localization could induce the loss-of-function effects.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
いきなり名医!パーキンソン病Q&A.
突然成为帕金森病问答的好医生!
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [Funayama M, et.al., 道川 誠, Hattori N, 道川誠, 道川誠, 服部信孝, 服部信孝]
通讯作者: 服部信孝
DOI: 10.1038/ng.485
发表时间: 2009-12-01
期刊: NATURE GENETICS
影响因子: 30.8
作者: [Satake, Wataru, Nakabayashi, Yuko, Toda, Tatsushi]
通讯作者: Toda, Tatsushi
DOI: 10.1016/j.febslet.2008.12.055
发表时间: 2009-02-04
期刊: FEBS LETTERS
影响因子: 3.5
作者: [Fukae, Jiro, Sato, Shigeto, Hattori, Nobutaka]
通讯作者: Hattori, Nobutaka
DOI: --
发表时间: 2008
期刊: Arch Neurol 65
影响因子: --
作者: [Kumazawa R, et.al.]
通讯作者: et.al.
18
    Autophagy lysosomal dysfunction associate with the pathogenesis of early onset Parkinson's disease.
    • 批准号:
      24390224
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.48万
    • 财政年份:
      2012
    • 负责人:
      HATTORI Nobutaka
    • 依托单位:
    Generation of pathological models for Parkinson's disease
    • 批准号:
      21390272
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.4万
    • 财政年份:
      2009
    • 负责人:
      HATTORI Nobutaka
    • 依托单位:
    Identification of a common pathway among gene products for familial Parkinson's disease and screening for a novel causative gene for
    • 批准号:
      19390244
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2007
    • 负责人:
      HATTORI Nobutaka
    • 依托单位:
    The analysis of Familial Parkinson's disease gene products and the research for identification of a novel Familial Parkinson's disease gene
    • 批准号:
      17390256
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.79万
    • 财政年份:
      2005
    • 负责人:
      HATTORI Nobutaka
    • 依托单位:
    国内基金
    海外基金
    红景天苷通过PINK1调控B细胞焦亡防治术后神经认知障碍的效应机制研究
    西红花苷通过SIRT3介导的PINK1去乙酰化调控线粒体自噬缓解心肌炎的机制研究
    丙泊酚经PINK1/Parkin通路介导线粒体自噬减轻老年患者髋关节置换术后睡眠剥夺相关心肌损伤的机制研究
    人脐带间充质干细胞来源的外泌体TRIM67介导METTL14/PINK1通路促进线粒体自噬抑制骨关节炎发展中软骨细胞铁死亡过程的机理研究
    • 批准号:
      2026JJ82195
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      阳曙东
    • 依托单位: